Micro Cap
Drug Manufacturers - Specialty & Generic
Stocks Ranked by
Market Capitalization
Micro Cap Drug Manufacturers - Specialty & Generic Stocks at a Glance
Specialty and generic drug manufacturers develop branded niche therapies, off-patent generics, and animal-health and cannabis products. Generics compete on price and manufacturing scale, while specialty brands carry pharma-like margins on smaller markets.
There are 35 micro cap Drug Manufacturers - Specialty & Generic stocks — companies in the Drug Manufacturers - Specialty & Generic industry with a market cap under $250M — worth a combined $2.41B.
The largest by market cap are Lifecore Biomedical (LFCR) at $243M, Canopy Growth (CGC) at $238M and SIGA Technologies (SIGA) at $197M.
Among institutional investors, Glass House Brands (GLAS) drew the most net new fund positions in Q2 2026: 50 funds opened new positions, taking total fund holders up 50 (1,667%) quarter-over-quarter.
- Combined market cap: $2.41B across 35 stocks.
- Micro Cap: market cap under $250M.
- Largest constituent: Lifecore Biomedical (LFCR), $243M market cap.
- Most net new fund positions in Q2 2026: Glass House Brands (GLAS), +50 holders.
Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q2 2026.